Chromogenic factor X-guided warfarin monitoring in lupus anticoagulant-positive primary antiphospholipid syndrome with adrenal hemorrhage and progressive deep vein thrombosis: a case report
Open Access
- 12 July 2026
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 20 (1)
Abstract
Antiphospholipid syndrome (APS) is a thrombotic autoimmune disorder; adrenal hemorrhage is uncommon. Treating progressive thrombosis with concurrent majorKeywords
This publication has 19 references indexed in Scilit:
- The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaArthritis & Rheumatology, 2023
- Rare benign adrenal lesionsEuropean Journal of Endocrinology, 2023
- Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndromeSeminars in Immunopathology, 2022
- Precision medicine and the antiphospholipid syndrome: what is the future?Clinical Rheumatology, 2020
- Thrombin generation and factor X assays for the assessment of warfarin anticoagulation in thrombotic antiphospholipid syndromeThrombosis Research, 2015
- The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical FeaturesAutoimmunity Reviews, 2015
- Antiphospholipid syndromeThe Lancet, 2010
- Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapyBlood Coagulation & Fibrinolysis, 2008
- Antiphospholipid syndrome and endocrine damage: why bilateral adrenal thrombosis?European Journal of Haematology, 2003
- Venous infarction of the adrenal glandsThe Journal of Pathology, 1976